Improvement of Predictive Value for Thromboembolic Risk by Incorporating Left Atrial Functional Parameters in the

Mi-Na Kim1, Su-A Kim, Jong-il Choi

  • 1Division of Cardiology, Korea University Anam Hospital.

Insights

Adding echocardiographic measures to atrial fibrillation risk scores improves prediction of blood clots. Combining impaired left atrial function with CHADS2 or CHA2DS2-VASc scores enhances embolic risk assessment in AF patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Medical Imaging

Background:

  • Atrial fibrillation (AF) poses a significant risk of thromboembolism.
  • Current risk stratification scores like CHADS2 and CHA2DS2-VASc have modest predictive ability.
  • Echocardiographic parameters are recognized risk factors for thromboembolic events.

Purpose of the Study:

  • To assess if combining echocardiographic parameters with CHADS2 and CHA2DS2-VASc scores improves embolic risk prediction in AF patients.
  • To evaluate the predictive power of clinical scores versus echocardiographic parameters for left atrial thrombus or dense spontaneous echo contrast (SEC).

Main Methods:

  • A total of 526 non-valvular AF patients were enrolled.
  • Predictability for left atrial (LA) thrombus or dense SEC was assessed using clinical scores, echocardiographic parameters, and combined approaches.
  • Statistical analysis included calculating c-statistics to compare predictive powers.

Main Results:

  • The predictive power of CHADS2 and CHA2DS2-VASc scores alone for LA thrombus/dense SEC was modest (c-statistics 0.65 and 0.68).
  • Impaired left atrial (LA) function (LA emptying fraction < 30%) emerged as the most significant echocardiographic predictor.
  • Combining impaired LA function with CHADS2 and CHA2DS2-VASc scores significantly improved prediction (c-statistics 0.78 and 0.77).

Conclusions:

  • Incorporating LA functional markers enhances the predictive value of CHADS2 and CHA2DS2-VASc scores for detecting thrombus or dense SEC.
  • Anticoagulation should be considered for AF patients with low-risk scores but also exhibiting LA dysfunction to prevent embolism.